Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended		191 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014
OPERATING ACTIVITIES
Net loss	$ (5,628,012)	$ (2,272,560)	$ (54,485,966)
Depreciation			52,694
Stock-based compensation-product development costs	17,847	4,497	554,210
Stock-based compensation-interest expenses	3,296,342		16,627,326
Stock-based compensation-selling, general and administration	105,045	63,959	3,591,835
Stock-based compensation-professional fees	44,610	111,928	262,384
Gain on settlement of debt	88,500		(317,220)
Stock-based compensation - market development			20,989
Non-cash imputed interest expenses	74,084	131,987	3,425,150
Accrued interest on line of credit	509,749	417,551	1,742,692
Equity instruments issued to settle liabilities			1,871,718
Other non-cash items included in net loss			341,629
Changes in operating assets and liabilities:
(Increase) decrease in prepaid expenses	1,225	16,253	(3,166)
Increase in accounts payable and accrued liabilities	90,966	89,372	1,661,132
Increase in interest payable	416,262	379,304	5,154,269
Increase in advances payable		30,000	3,152,071
Income tax receivable			8,727
Net cash used in operating activities	(1,160,382)	(1,027,708)	(16,110,806)
INVESTING ACTIVITIES
Purchase of equipment			(43,078)
Net cash used in investing activities			(43,078)
FINANCING ACTIVITIES
Proceeds from borrowings on line of credit	1,179,850	1,073,638	6,700,222
Proceeds from issuance of promissory notes			9,418,676
Proceeds from issuance of shares			1,512,403
Repayment of promissory notes payable		(20,000)	(970,879)
Expenditures to repurchase shares			(342,038)
Other financing activities			(115,472)
Net cash provided by financing activities	1,179,850	1,053,638	16,202,912
Increase in cash	19,470	25,930	49,028
Cash, beginning of period	29,558	11,082
Cash, end of period	49,028	37,012	49,028
Shares issued to settle liabilities	$ 86,000	$ 30,000